Who
Barbara W. Bodem
Director
Company insider
Files Form 4 as: Director, BioMarin Pharmaceutical; Director, Option Care Health; Director, Enovis; Director, Syneos Health; Director, Turning Point Therapeutics; SVP, Chief Financial Officer, Hill-Rom Holdings; Director, Invacare.
In numbers
- Trades disclosed
- 75
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 7
- Companies where not an officer
- 6
- First trade
- 18 Aug 2017
- Last trade
- 2 Jun 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jun 2026filed 4 Jun 2026 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code A | —7,490 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code A | —7,490 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | OPCH Option Care HealthProviders & Facilities | SEC FORM 4 Code A | —8,997 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | OPCH Option Care HealthProviders & Facilities | SEC FORM 4 Code A | —8,997 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | ENOV EnovisMedical Devices | SEC FORM 4 Code A | —9,346 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | ENOV EnovisMedical Devices | SEC FORM 4 Code A | —9,346 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | ENOV EnovisMedical Devices | SEC FORM 4 Code A | —6,598 at $0.00 | filing |
| 20 May 2025filed 22 May 2025 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code A | —6,650 at $0.00 | filing |
| 14 May 2025filed 19 May 2025 | OPCH Option Care HealthProviders & Facilities | SEC FORM 4 Code A | —5,034 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code A | —4,720 at $0.00 | filing |
| 20 May 2024filed 22 May 2024 | ENOV EnovisMedical Devices | SEC FORM 4 Code A | —4,338 at $0.00 | filing |
| 15 May 2024filed 17 May 2024 | OPCH Option Care HealthProviders & Facilities | SEC FORM 4 Code A | —5,325 at $0.00 | filing |
| 1 Apr 2024filed 3 Apr 2024 | OPCH Option Care HealthProviders & Facilities | SEC FORM 4 Code A | —1,731 at $0.00 | filing |
| 27 Dec 2023filed 28 Dec 2023 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code A | —2,180 at $0.00 | filing |
| 28 Sep 2023filed 28 Sep 2023 | Syneos Health | SEC FORM 4 Code D | $151K3,522 at $43.00 | filing |
| 28 Sep 2023filed 28 Sep 2023 | Syneos Health | SEC FORM 4 Code D | —4,863 at $0.00 | filing |
| 25 May 2023filed 30 May 2023 | Syneos Health | SEC FORM 4 Code A | —4,863 at $0.00 | filing |
| 16 May 2023filed 18 May 2023 | ENOV Enovisoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,167 at $0.00 | filing |
| 16 May 2023filed 18 May 2023 | ENOV EnovisMedical Devices | SEC FORM 4 Code A | —1,875 at $0.00 | filing |
| 17 Aug 2022filed 17 Aug 2022 | Turning Point Therapeuticsoption or derivative | SEC FORM 4 Code D | —14,995 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.
Related people
Nobody else traded the same names lately.